Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
July 13, 2012
Primary hyperparathyroidism and vitamin D in African Americans
Jaisri Maharaj, Michael J Haas, Kent R Wehmeier
Nutrition Research (New York, N.Y.)
|
December 29, 2024
Vitamin D, immune function, and atherosclerosis. Where are we now?
Ailyn Rivero, Kent R Wehmeier, Michael J Haas, et al.
Obesity (Silver Spring, Md.)
|
April 5, 2008
Obesity-related changes in high-density lipoprotein metabolism
Arshag D Mooradian, Michael J Haas, Kent R Wehmeier, et al.
Hepatology (Baltimore, Md.)
|
September 27, 2003
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
Brent A Neuschwander-Tetri, Elizabeth M Brunt, Kent R Wehmeier, et al.
Free Radical Biology & Medicine
|
July 27, 2016
Inhibition of endoplasmic reticulum stress and oxidative stress by vitamin D in endothelial cells
Michael J Haas, Mohammad Jafri, Kent R Wehmeier, et al.
Human Pathology
|
September 3, 2004
Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens
Elizabeth M Brunt, Brent A Neuschwander-Tetri, Dana Oliver, et al.
Calcified Tissue International
|
January 14, 2016
Inhibition of ABCA1 Protein Expression and Cholesterol Efflux by TNF α in MLO-Y4 Osteocytes
Kent R Wehmeier, William Kurban, Chandrikha Chandrasekharan, et al.
Journal of Hepatology
|
March 29, 2003
Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
Brent A Neuschwander-Tetri, Elizabeth M Brunt, Kent R Wehmeier, et al.
Life Sciences
|
November 11, 2010
24, 25-dihydroxycholecalciferol but not 25-hydroxycholecalciferol suppresses apolipoprotein A-I gene expression
Kent R Wehmeier, Abdul-Razzak Alamir, Senan Sultan, et al.
Biochimica Et Biophysica Acta
|
December 18, 2007
Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators
Kent R Wehmeier, Angela Mazza, Sahar Hachem, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
July 13, 2012
Primary hyperparathyroidism and vitamin D in African Americans
Jaisri Maharaj, Michael J Haas, Kent R Wehmeier
Nutrition Research (New York, N.Y.)
|
December 29, 2024
Vitamin D, immune function, and atherosclerosis. Where are we now?
Ailyn Rivero, Kent R Wehmeier, Michael J Haas, et al.
Obesity (Silver Spring, Md.)
|
April 5, 2008
Obesity-related changes in high-density lipoprotein metabolism
Arshag D Mooradian, Michael J Haas, Kent R Wehmeier, et al.
Hepatology (Baltimore, Md.)
|
September 27, 2003
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
Brent A Neuschwander-Tetri, Elizabeth M Brunt, Kent R Wehmeier, et al.
Free Radical Biology & Medicine
|
July 27, 2016
Inhibition of endoplasmic reticulum stress and oxidative stress by vitamin D in endothelial cells
Michael J Haas, Mohammad Jafri, Kent R Wehmeier, et al.
Human Pathology
|
September 3, 2004
Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens
Elizabeth M Brunt, Brent A Neuschwander-Tetri, Dana Oliver, et al.
Calcified Tissue International
|
January 14, 2016
Inhibition of ABCA1 Protein Expression and Cholesterol Efflux by TNF α in MLO-Y4 Osteocytes
Kent R Wehmeier, William Kurban, Chandrikha Chandrasekharan, et al.
Journal of Hepatology
|
March 29, 2003
Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
Brent A Neuschwander-Tetri, Elizabeth M Brunt, Kent R Wehmeier, et al.
Life Sciences
|
November 11, 2010
24, 25-dihydroxycholecalciferol but not 25-hydroxycholecalciferol suppresses apolipoprotein A-I gene expression
Kent R Wehmeier, Abdul-Razzak Alamir, Senan Sultan, et al.
Biochimica Et Biophysica Acta
|
December 18, 2007
Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators
Kent R Wehmeier, Angela Mazza, Sahar Hachem, et al.
Page
of 2